Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|11|1|115-128

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.11, Iss.1, 2010-01, pp. : 115-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of genes across the doxorubicin pathway

By Jamieson David   Boddy Alan V  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1201-1210

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of Target Genes Across the Warfarin Pharmacological Pathway

By Lal Suman  

Clinical Pharmacokinetics, Vol. 45, Iss. 12, 2006-01 ,pp. : 1189-1200

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review

By  

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 209-217

Bentham Science Publishers

Access to resources Recommend Favorite

From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes

By Serretti Alessandro   Artioli Paola  

Psychopharmacology, Vol. 174, Iss. 4, 2004-08 ,pp. : 490-503

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of the PPAR genes and cardiovascular disease

By Cresci Sharon  

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1581-1595

Future Medicine

Access to resources Recommend Favorite